Madeleine Duvic
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, T-cell and Retrovirus Studies, Fungal Infections and Studies, Nail Diseases and Treatments
Most-Cited Works
- → Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)(2007)1,399 cited
- → Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)(2006)1,133 cited
- → Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma(2007)1,038 cited
- → Genome-wide association study in alopecia areata implicates both innate and adaptive immunity(2010)800 cited
- → Alopecia areata investigational assessment guidelines–Part II(2004)771 cited
- → Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results